Vaccines and Antibiotic Resistance (AUDIO)
Caption
The 13-valent pneumococcal conjugate vaccine (PCV13) has been hugely successful -- reducing severe antibiotic-resistant infections such as pneumonia and meningitis in young children by 62 percent in the four years since it was introduced. Recommended for all children under five years old, PCV13 is proving to be part of the solution to protecting ourselves from the growing threat of antibiotic resistance. The vaccine is so effective it helped Healthy People 2020 meet its goal to decrease antibiotic-resistant invasive pneumococcal disease nine years early.
Credit
IDWeek
Usage Restrictions
Please do not repost until 11/10.
License
Licensed content